Improvement of level MDA and SOD Using of Ganoderma Lucidum as Adjunctive Treatment for Statin Based Therapy in High Risk Patient Based on Framingham Score
It is well known from previous research on the importance of antioxidants to inhibit the progression of coronary heart disease in high-risk patients based on framingham scores. Statins are routinely administered in high-risk patients based on the Dyslipidemia 2016 ESC guidelines but the effects of...
Saved in:
Published in | Majalah kardiologi Indonesia Vol. 39; no. 3 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Indonesian Heart Association
11.09.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | It is well known from previous research on the importance of antioxidants to inhibit the progression of coronary heart disease in high-risk patients based on framingham scores. Statins are routinely administered in high-risk patients based on the Dyslipidemia 2016 ESC guidelines but the effects of adding Ganoderma are known to have antioxidant effects, in patients who have received statins. This study aims to assess the effect of antioxidants through measurement of SOD and MDA in patients given a combination of Ganoderma lucidum with statins.Method: A total of 24 patients with high-risk patients based on the Framingham score > 20% were selected as sample of study. Patients with respondents who had never received statin therapy or ACEi or ARB or CCB or beta blocker, or did not routinely consume the drug for 2 weeks were excluded from this study. The addition of Ganoderma lucidum dose of 3x250 mg was added to statins as the first group and Ganoderma lucidum dose of 3x250 mg was added to the Statin combination of Angiotensin Converting Enzym inhibitors (ACE inhibitors) or Angiotensin Receptor Blockers (ARB) and or Calcium Channel Blockers (CCB) and or Beta blockers as second group for 90 days. SOD and MDA levels were measured before and after the administration of Ganoderma Lucidum with the ELISA method.Result: After the administration of Ganoderma Lucidum with standard therapy, there was a decrease in MDA levels and an increase in SOD levels after 90 days in two groups. Conclusion: The addition of Ganoderma Lucidum to standard therapy can reduce oxidant levels in high-risk patients based on framingham scores.
Keyword: Superoxyde-dismutase, Malondyaldehide, Oxidative Stress, Antioxidant, Ganoderma Lucidum, Statin |
---|---|
AbstractList | It is well known from previous research on the importance of antioxidants to inhibit the progression of coronary heart disease in high-risk patients based on framingham scores. Statins are routinely administered in high-risk patients based on the Dyslipidemia 2016 ESC guidelines but the effects of adding Ganoderma are known to have antioxidant effects, in patients who have received statins. This study aims to assess the effect of antioxidants through measurement of SOD and MDA in patients given a combination of Ganoderma lucidum with statins.Method: A total of 24 patients with high-risk patients based on the Framingham score > 20% were selected as sample of study. Patients with respondents who had never received statin therapy or ACEi or ARB or CCB or beta blocker, or did not routinely consume the drug for 2 weeks were excluded from this study. The addition of Ganoderma lucidum dose of 3x250 mg was added to statins as the first group and Ganoderma lucidum dose of 3x250 mg was added to the Statin combination of Angiotensin Converting Enzym inhibitors (ACE inhibitors) or Angiotensin Receptor Blockers (ARB) and or Calcium Channel Blockers (CCB) and or Beta blockers as second group for 90 days. SOD and MDA levels were measured before and after the administration of Ganoderma Lucidum with the ELISA method.Result: After the administration of Ganoderma Lucidum with standard therapy, there was a decrease in MDA levels and an increase in SOD levels after 90 days in two groups. Conclusion: The addition of Ganoderma Lucidum to standard therapy can reduce oxidant levels in high-risk patients based on framingham scores. Keyword: Superoxyde-dismutase, Malondyaldehide, Oxidative Stress, Antioxidant, Ganoderma Lucidum, Statin It is well known from previous research on the importance of antioxidants to inhibit the progression of coronary heart disease in high-risk patients based on framingham scores. Statins are routinely administered in high-risk patients based on the Dyslipidemia 2016 ESC guidelines but the effects of adding Ganoderma are known to have antioxidant effects, in patients who have received statins. This study aims to assess the effect of antioxidants through measurement of SOD and MDA in patients given a combination of Ganoderma lucidum with statins.Method: A total of 24 patients with high-risk patients based on the Framingham score > 20% were selected as sample of study. Patients with respondents who had never received statin therapy or ACEi or ARB or CCB or beta blocker, or did not routinely consume the drug for 2 weeks were excluded from this study. The addition of Ganoderma lucidum dose of 3x250 mg was added to statins as the first group and Ganoderma lucidum dose of 3x250 mg was added to the Statin combination of Angiotensin Converting Enzym inhibitors (ACE inhibitors) or Angiotensin Receptor Blockers (ARB) and or Calcium Channel Blockers (CCB) and or Beta blockers as second group for 90 days. SOD and MDA levels were measured before and after the administration of Ganoderma Lucidum with the ELISA method.Result: After the administration of Ganoderma Lucidum with standard therapy, there was a decrease in MDA levels and an increase in SOD levels after 90 days in two groups. Conclusion: The addition of Ganoderma Lucidum to standard therapy can reduce oxidant levels in high-risk patients based on framingham scores. Keyword: Superoxyde-dismutase, Malondyaldehide, Oxidative Stress, Antioxidant, Ganoderma Lucidum, Statin |
Author | Vitriyaturrida, Vitriyaturrida Hendrawan, Dadang Rohman, M Saifur Sargowo, Djanggan |
Author_xml | – sequence: 1 givenname: Vitriyaturrida surname: Vitriyaturrida fullname: Vitriyaturrida, Vitriyaturrida – sequence: 2 givenname: M Saifur surname: Rohman fullname: Rohman, M Saifur – sequence: 3 givenname: Djanggan surname: Sargowo fullname: Sargowo, Djanggan – sequence: 4 givenname: Dadang surname: Hendrawan fullname: Hendrawan, Dadang |
BookMark | eNo9kdtqGzEQhkVJoW6a217rBdbVyZL20k2axOCQUDvXYlYHW65XMtLakGfJy3Zjl14N_PPzDcz3FV2lnDxC3ymZcqII_RF3dnribeRTzcgnNGGSkUYoya7QhFAmG64U_4Juat0RQhhVpNV8gt4X_aHkk-99GnAOeO9Pfo-f7uYYksOr5zv8WmPafKweIGXnSw94ebTRHXsMFc_d7pjsEE8er4uH4cwJueDVAENM-CdU7_B66wsc3vAYPMbNFv-O9Q9-GQsf7UslJ3xfoB9vbaHHK5uL_4Y-B9hXf_NvXqPX-1_r28dm-fywuJ0vG0vJjDbgpZi1zDrLQwuKOSBcguwkEbLtHFVcCBAd7yhTgrRCeq0UEUyMb9GOBn6NFheuy7AzhxJ7KG8mQzTnIJeNgTJEu_eGSKcVOBs0ZUKD1KHTHQclnZq1PNCRNb2wbMm1Fh_-8ygxZ1NmNGXOpsxoiv8FOPWIog |
ContentType | Journal Article |
DBID | AAYXX CITATION DOA |
DOI | 10.30701/ijc.v39i3.820 |
DatabaseName | CrossRef Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2620-4762 |
ExternalDocumentID | oai_doaj_org_article_06d87adcf81248a68fb8b3a76d7593f1 10_30701_ijc_v39i3_820 |
GroupedDBID | AAYXX ALMA_UNASSIGNED_HOLDINGS CITATION GROUPED_DOAJ OK1 |
ID | FETCH-LOGICAL-c1051-ae64592cdc3f9a72da036a6b60469bd17344a4b3b12740946e87704240128d1f3 |
IEDL.DBID | DOA |
ISSN | 0126-3773 |
IngestDate | Thu Jul 04 21:04:41 EDT 2024 Fri Aug 23 02:25:52 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1051-ae64592cdc3f9a72da036a6b60469bd17344a4b3b12740946e87704240128d1f3 |
OpenAccessLink | https://doaj.org/article/06d87adcf81248a68fb8b3a76d7593f1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_06d87adcf81248a68fb8b3a76d7593f1 crossref_primary_10_30701_ijc_v39i3_820 |
PublicationCentury | 2000 |
PublicationDate | 2019-09-11 |
PublicationDateYYYYMMDD | 2019-09-11 |
PublicationDate_xml | – month: 09 year: 2019 text: 2019-09-11 day: 11 |
PublicationDecade | 2010 |
PublicationTitle | Majalah kardiologi Indonesia |
PublicationYear | 2019 |
Publisher | Indonesian Heart Association |
Publisher_xml | – name: Indonesian Heart Association |
SSID | ssj0002170983 |
Score | 2.1277552 |
Snippet | It is well known from previous research on the importance of antioxidants to inhibit the progression of coronary heart disease in high-risk patients based on... |
SourceID | doaj crossref |
SourceType | Open Website Aggregation Database |
SubjectTerms | Superoxide-dismutase, Malondyaldehide, Stres oksidatif, Antioxidan, Ganoderma Lucidum, Statin |
Title | Improvement of level MDA and SOD Using of Ganoderma Lucidum as Adjunctive Treatment for Statin Based Therapy in High Risk Patient Based on Framingham Score |
URI | https://doaj.org/article/06d87adcf81248a68fb8b3a76d7593f1 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NS8QwEA3iyYsoKn4zB8FTtWnapD2uH6uIq6IreCv5xKrbFXX9M_5ZZ5pV9ubFaxraMkzz3msmbxjbo-7lhVVZknqbJrkpQ1JZrRKe-YpnVoU0pYPCgyt5fp9fPBQPM62-qCYs2gPHwB2m0pVKOxsIiUoty2BKI7SSThWVCFH48GJGTNEajEQ7raIHJ88kfkVKRMdGSnF-2DzZg09RNeKgpEbfM4g0Y9zfIUx_iS1OqSH04istsznfrrCvqPq7n3gwDvBCRT4wOOmBbh3cXZ9At-lPl850S43NRhouJ7ZxkxHod-i5J0QuWtNg-FNTDkhUgVhm08IRopiDYfQWABygwg-4bd6f4SZark6njFtAkjvCZz3qEdyR--Uqu--fDo_Pk2lDhcQijeKJ9mQdk1lnRai0ypxG_NLSSBLJxnEl8lznRhiOWhV1n_SlUrQ3SijmeBBrbL4dt36dAfmoGWR3hcWpuN5XwWsVnNd5GoyTfIPt_wS1fo2-GTXqjS78NYa_7sJfY_g32BHF_HcW-V13A5gF9TQL6r-yYPM_brLFFpAOdRVknG-z-Y-3id9ByvFhdrvs-gZJRtLB |
link.rule.ids | 315,786,790,870,2115,27957,27958 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improvement+of+level+MDA+and+SOD+Using+of+Ganoderma+Lucidum+as+Adjunctive+Treatment+for+Statin+Based+Therapy+in+High+Risk+Patient+Based+on+Framingham+Score&rft.jtitle=Majalah+kardiologi+Indonesia&rft.au=vitriyaturrida+vitriyaturrida&rft.au=M+Saifur+Rohman&rft.au=Djanggan+Sargowo&rft.au=Dadang+Hendrawan&rft.date=2019-09-11&rft.pub=Indonesian+Heart+Association&rft.issn=0126-3773&rft.eissn=2620-4762&rft.volume=39&rft.issue=3&rft_id=info:doi/10.30701%2Fijc.v39i3.820&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_06d87adcf81248a68fb8b3a76d7593f1 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0126-3773&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0126-3773&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0126-3773&client=summon |